Improving Cardiovascular Risk in Postmenopausal Women with an (−)-Epicatechin-Based Nutraceutical: A Randomly Assigned, Double-Blind vs. Placebo, Proof-of-Concept Trial

Improving Cardiovascular Risk in Postmenopausal Women with an (−)-Epicatechin-Based Nutraceutical: A Randomly Assigned, Double-Blind vs. Placebo, Proof-of-Concept Trial

Background: Age-adjusted rates of cardiovascular disease (CVD) are higher in men than in women. CVD risk-factor outcomes are underrecognized, underestimated, and undertreated in women because the clinical expressions in women differ from those of men. There are no universally accepted recommendation...

Full description

Bibliographic Details
Main Authors: Nayelli Nájera, Miguel Ortíz-Flores, Javier Pérez-Durán, Enrique Reyes-Muñoz, José Romo-Yañez, Guillermo Ortiz-Luna, Francisco Villarreal, Eduardo Meaney, Guillermo Ceballos, Araceli Montoya-Estrada
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Journal of Clinical Medicine
Subjects:
cardiovascular risk
lipoprotein subfractionation profile
epicatechin
(−)-epicatechin-enriched cacao
Online Access:https://www.mdpi.com/2077-0383/13/1/195

Internet

https://www.mdpi.com/2077-0383/13/1/195

Similar Items